Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Innate Pharma S.A. ADR (IPHA)

Innate Pharma S.A. ADR (IPHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Innate Pharma S.A. ADR 117 AVENUE DE LUMINY BP 30191 MARSEILLE I0 13009 FRA

www.innate-pharma.com P: 33-4-30-30-30-30 F: +33 430303000

Description:

Innate Pharma S.A. is a commercial stage oncology-focused biotech company. It discovers and develops therapeutic antibodies for the treatment of cancer. The company's commercial-stage product includes Lumoxiti. Innate Pharma S.A. is based in Marseille, France.

Key Statistics

Overview:

Market Capitalization, $K 191,641
Enterprise Value, $K 158,391
Shares Outstanding, K 80,861
Annual Sales, $ 66,710 K
Annual Net Income, $ -8,190 K
EBIT, $ 0 K
EBITDA, $ -8,200 K
60-Month Beta 0.30
% of Insider Shareholders 31.89%
% of Institutional Shareholders 0.16%
Float, K 55,074
% Float 68.11%
Short Volume Ratio 0.65

Growth:

1-Year Return -14.76%
3-Year Return -41.98%
5-Year Return 0.00%
5-Year Revenue Growth -39.88%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Latest Earnings Date 03/21/24
Earnings Per Share ttm 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00%

IPHA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % 0.00%
Return-on-Assets % 0.00%
Profit Margin % -12.28%
Debt/Equity 0.77
Price/Sales 2.94
Price/Cash Flow N/A
Price/Book 3.51
Book Value/Share 0.69
Interest Coverage -3.12
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar